North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...

US medical device company Abbott has said it plans to launch a new range of 'biowearable' health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring.

We recently compiled a list of the Diamond Hill Capital’s Top 10 Stock Picks. In this article, we are going to take a look at ...

Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $114.25 which represents a slight increase of $0.85 or 0.75% from the prior close of $113.4. The stock opened at $113.54 and ...

Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $113.83 which represents a slight increase of $0.39 or 0.34% from the prior close of $113.44. The stock opened at $113.94 and ...